Advertisement
Screener

HUMAN GENOME SCIENCES INC Increase (Decrease) in Inventories

HUMAN GENOME SCIENCES INC Increase (Decrease) in Inventories

HUMAN GENOME SCIENCES INC reported Increase (Decrease) in Inventories of $4.59 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-07-26.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInInventories · last filed 2012-07-26

  • HUMAN GENOME SCIENCES INC increase (decrease) in inventories for the quarter ending 2012-06-30 was $578.00K, a 97.65% decline year-over-year.
  • HUMAN GENOME SCIENCES INC increase (decrease) in inventories for the quarter ending 2012-03-31 was $4.02M, a 85.67% decline year-over-year.
  • HUMAN GENOME SCIENCES INC increase (decrease) in inventories for the quarter ending 2011-12-31 was $31.28M, a 84.31% increase year-over-year.
  • HUMAN GENOME SCIENCES INC increase (decrease) in inventories for the quarter ending 2011-09-30 was $23.11M, a 705.40% increase year-over-year.
  • HUMAN GENOME SCIENCES INC increase (decrease) in inventories for fiscal 2011 was $107.02M, a 366.47% increase from fiscal 2010.
  • HUMAN GENOME SCIENCES INC increase (decrease) in inventories for fiscal 2010 was $22.94M, a 13.86% increase from fiscal 2009.
  • HUMAN GENOME SCIENCES INC increase (decrease) in inventories for fiscal 2009 was $20.15M.
Period endIncrease (Decrease) in Inventories 3 monthIncrease (Decrease) in Inventories 6 monthIncrease (Decrease) in Inventories 9 monthIncrease (Decrease) in Inventories 12 month
2012-06-30$578.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26
$4.59M
10-Q · filed 2012-07-26
$35.88M
derived: sum of 3 quarters · filed 2012-07-26
$58.99M
derived: sum of 4 quarters · filed 2012-07-26
2012-03-31$4.02M
10-Q · filed 2012-04-26
$35.30M
derived: sum of 2 quarters · filed 2012-04-26
$58.41M
derived: sum of 3 quarters · filed 2012-04-26
$83.01M
derived: sum of 4 quarters · filed 2012-07-26
2011-12-31$31.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28
$54.40M
derived: sum of 2 quarters · filed 2012-02-28
$78.99M
derived: sum of 3 quarters · filed 2012-07-26
$107.02M
10-K · filed 2012-02-28
2011-09-30$23.11M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28
$47.71M
derived: sum of 2 quarters · filed 2012-07-26
$75.74M
10-Q · filed 2011-10-28
$92.71M
derived: sum of 4 quarters · filed 2012-07-26
2011-06-30$24.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26
$52.62M
10-Q · filed 2012-07-26
$69.59M
derived: sum of 3 quarters · filed 2012-07-26
$72.46M
derived: sum of 4 quarters · filed 2012-07-26
2011-03-31$28.02M
10-Q · filed 2012-04-26
$45.00M
derived: sum of 2 quarters · filed 2012-04-26
$47.87M
derived: sum of 3 quarters · filed 2012-04-26
$50.89M
derived: sum of 4 quarters · filed 2012-04-26
2010-12-31$16.97M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28
$19.84M
derived: sum of 2 quarters · filed 2012-02-28
$22.87M
derived: sum of 3 quarters · filed 2012-02-28
$22.94M
10-K · filed 2012-02-28
2010-09-30$2.87M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28
$5.89M
derived: sum of 2 quarters · filed 2011-10-28
$5.97M
10-Q · filed 2011-10-28
2010-06-30$3.02M
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28
$3.10M
10-Q · filed 2011-07-28
2010-03-31$76.00K
10-Q · filed 2011-04-29
2009-12-31$20.15M
10-K · filed 2012-02-28